SLGL Sol-Gel Technologies Ltd. - Ordinary Shares

NASDAQ · Pharmaceuticals
$80.04
Price · Aug 19, 2026

SLGL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$80.04
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$16 – $98

SLGL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
SLGL
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
SLGL
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
SLGL
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
SLGL
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
SLGL
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
SLGL
Peer Median

SLGL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 2 20.0%
  • Buy 7 70.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-17
Median target $184.00 +129.9%
Mean target $193.00 +141.1%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.38%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-1.31 $-1.88 0.57%
Dec. 31, 2025 $-1.07 $0.40 -1.5%
Sept. 30, 2025 $-2.13 $-2.13 0.00%
Sept. 30, 2024 $-0.10 $-1.33 1.2%
June 30, 2024 $0.70 $-2.04 2.7%
March 31, 2024 $-2.30 $-1.53 -0.77%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
SLGL
MDWD
PYPD

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 24 filers · $96.9M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
5 (-4 vs prior Q) 2 (0 vs prior Q) 7 (+3 vs prior Q) 6 (+3 vs prior Q) +67K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Opaleye Management Inc. $37,070,000 500,000 38.26% Shares
GREAT POINT PARTNERS LLC $20,341,273 274,363 21.00% Shares
Phoenix Financial Ltd. $10,835,316 146,147 11.18% Shares
Trails Edge Capital Partners, LP $10,338,452 139,445 10.67% Shares
Affinity Asset Advisors, LLC $6,294,486 84,900 6.50% Shares
Squadron Capital Management LLC $3,855,280 52,000 3.98% Shares
CITADEL ADVISORS LLC $2,396,131 32,319 2.47% Shares
GILDER GAGNON HOWE & CO LLC $1,668,150 22,500 1.72% Shares
Stonepine Capital Management, LLC $1,072,732 14,469 1.11% Shares
Yelin Lapidot Holdings Management Ltd. $769,870 10,384 0.79% Shares
MENORA MIVTACHIM HOLDINGS LTD. $564,280 7,611 0.58% Shares
NAVELLIER & ASSOCIATES INC $428,900 5,785 0.44% Shares
LPL Financial LLC $289,443 3,904 0.30% Shares
MILLENNIUM MANAGEMENT LLC $247,776 3,342 0.26% Shares
XTX Topco Ltd $220,492 2,974 0.23% Shares
JANE STREET GROUP, LLC $207,518 2,799 0.21% Shares
TWO SIGMA SECURITIES, LLC $200,771 2,708 0.21% Shares
BlackRock, Inc. $47,820 645 0.05% Shares
UBS Group AG $17,200 232 0.02% Shares
Tower Research Capital LLC (TRC) $7,414 100 0.01% Shares
SBI Securities Co., Ltd. $5,338 72 0.01% Shares
MORGAN STANLEY $1,779 24 0.00% Shares
HRT FINANCIAL LP $463 6,256 0.00% Shares
Allworth Financial LP $371 5 0.00% Shares

Company insiders 1 insider · 0 officers · 0 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Opaleye Management Inc. Aug. 12, 2026 P 494,887 7 0 $355,078

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Moshe Arkin, M. Arkin Dermatology Ltd. ×3 filings April 15, 2026 56.60% Amendment SEC
M. Arkin Dermatology Ltd., Moshe Arkin ×5 filings April 8, 2024 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
QQQS · Invesco Exchange-Traded Fund Trust … 0.59% 1,515 SH Aug. 8, 2026 Daily